Stakheev, D.; Taborska, P.; Kalkusova, K.; Bartunkova, J.; Smrz, D.
LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. Pharmaceutics 2022, 14, 2747.
https://doi.org/10.3390/pharmaceutics14122747
AMA Style
Stakheev D, Taborska P, Kalkusova K, Bartunkova J, Smrz D.
LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. Pharmaceutics. 2022; 14(12):2747.
https://doi.org/10.3390/pharmaceutics14122747
Chicago/Turabian Style
Stakheev, Dmitry, Pavla Taborska, Katerina Kalkusova, Jirina Bartunkova, and Daniel Smrz.
2022. "LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy" Pharmaceutics 14, no. 12: 2747.
https://doi.org/10.3390/pharmaceutics14122747
APA Style
Stakheev, D., Taborska, P., Kalkusova, K., Bartunkova, J., & Smrz, D.
(2022). LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. Pharmaceutics, 14(12), 2747.
https://doi.org/10.3390/pharmaceutics14122747